Cwm, LLC Takeda Pharmaceutical CO LTD Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Cwm, LLC holds 9,373 shares of TAK stock, worth $133,940. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,373

Previous 6,822 37.39%

Holding current value

$133,940

Previous $105,000 30.48%

% of portfolio

0.0%

Previous 0.0%

35 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$13.6 - $15.52 $34,693 - $39,591	2,551 Added 37.39%	9,373 $137,000
Q2 2025 Jul 25, 2025	SELL	$13.71 - $15.46 $8,171 - $9,214	-596 Reduced 8.03%	6,822 $105,000
Q1 2025 May 01, 2025	SELL	$12.89 - $15.19 $28,125 - $33,144	-2,182 Reduced 22.73%	7,418 $110,000
Q4 2024 Feb 04, 2025	BUY	$13.01 - $14.43 $35,972 - $39,898	2,765 Added 40.45%	9,600 $127,000
Q3 2024 Oct 08, 2024	BUY	$13.0 - $15.08 $30,628 - $35,528	2,356 Added 52.6%	6,835 $97,000

Q2 2024 Jul 09, 2024	SELL	$12.6 - $13.67 $17,299 - $18,768	-1,373 Reduced 23.46%	4,479 $58,000
Q1 2024 Apr 05, 2024	BUY	$13.89 - $15.04 $6,569 - $7,113	473 Added 8.79%	5,852 $81,000
Q4 2023 Feb 01, 2024	SELL	$13.36 - $15.43 $11,489 - $13,269	-860 Reduced 13.78%	5,379 $77,000
Q3 2023 Oct 11, 2023	BUY	$15.03 - $16.32 $766 - $832	51 Added 0.82%	6,239 $97,000
Q2 2023 Aug 03, 2023	BUY	$15.57 - $17.11 $965 - $1,060	62 Added 1.01%	6,188 $97,000
Q1 2023 Apr 28, 2023	BUY	$15.28 - $16.48 $19,359 - $20,880	1,267 Added 26.08%	6,126 $101,000
Q4 2022 Feb 01, 2023	SELL	$12.42 - $15.62 $9,923 - $12,480	-799 Reduced 14.12%	4,859 $76,000
Q3 2022 Oct 27, 2022	BUY	$12.8 - $28.65 $26,150 - $58,531	2,043 Added 56.51%	5,658 $73,000
Q2 2022 Jul 28, 2022	BUY	$13.12 - $15.03 $23,996 - $27,489	1,829 Added 102.41%	3,615 $51,000
Q1 2022 Apr 21, 2022	BUY	$13.54 - $15.35 $4,644 - $5,265	343 Added 23.77%	1,786 $26,000
Q4 2021 Jan 31, 2022	BUY	$13.17 - $16.4 $4,477 - $5,575	340 Added 30.83%	1,443 $20,000
Q1 2021 Sep 15, 2021	BUY	$16.71 - $19.9 $1,654 - $1,970	99 Added 9.86%	1,103 $19,000
Q1 2021 Apr 27, 2021	SELL	$16.71 - $19.9 $1,654 - $1,970	-99 Reduced 8.98%	1,004 $18,000
Q4 2020 Sep 15, 2021	BUY	$15.39 - $18.97 $1,523 - $1,878	99 Added 9.86%	1,103 $19,000
Q4 2020 Jan 27, 2021	SELL	$15.39 - $18.97 $1,523 - $1,878	-99 Reduced 8.98%	1,004 $18,000
Q3 2020 Sep 15, 2021	SELL	$17.1 - $19.19 $15,732 - $17,654	-920 Reduced 45.48%	1,103 $19,000
Q3 2020 Oct 19, 2020	BUY	$17.1 - $19.19 $15,732 - $17,654	920 Added 83.41%	2,023 $36,000
Q2 2020 Sep 15, 2021	SELL	$14.59 - $19.5 $10,300 - $13,767	-706 Reduced 39.03%	1,103 $19,000
Q2 2020 Jul 22, 2020	BUY	$14.59 - $19.5 $10,300 - $13,767	706 Added 64.01%	1,809 $32,000
Q1 2020 Sep 15, 2021	SELL	$13.02 - $20.31 $9,647 - $15,049	-741 Reduced 40.18%	1,103 $19,000
Q1 2020 Apr 28, 2020	BUY	$13.02 - $20.31 $9,647 - $15,049	741 Added 67.18%	1,844 $28,000
Q4 2019 Sep 14, 2021	SELL	$16.88 - $20.83 $19,125 - $23,600	-1,133 Reduced 50.67%	1,103 $19,000
Q4 2019 Jan 27, 2020	BUY	$16.88 - $20.83 $19,125 - $23,600	1,133 Added 102.72%	2,236 $44,000
Q3 2019 Sep 14, 2021	BUY	$16.15 - $17.99 $4,715 - $5,253	292 Added 36.0%	1,103 $19,000
Q3 2019 Oct 22, 2019	SELL	$16.15 - $17.99 $4,715 - $5,253	-292 Reduced 26.47%	811 $14,000
Q2 2019 Sep 14, 2021	BUY	$16.58 - $20.49 $630 - $778	38 Added 3.57%	1,103 $19,000
Q2 2019 Jul 31, 2019	SELL	$16.58 - $20.49 $630 - $778	-38 Reduced 3.45%	1,065 $19,000
Q1 2019 Sep 02, 2021	BUY	$16.7 - $21.52 $6,680 - $8,608	400 Added 56.9%	1,103 $0
Q1 2019 Apr 22, 2019	BUY	$16.7 - $21.52 $8,032 - $10,351	481 Added 216.67%	703 $14,000
Q4 2018 Jan 25, 2019	BUY	$15.64 - $21.1 $3,472 - $4,684	222 New	222 $4,000

Others Institutions Holding TAK

# of Institutions

382

Shares Held

80.7M

Call Options Held

1.67M

Put Options Held

276K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account